March 21, 2025
Analysis | Newest Hartford Healthcare Lawsuit Adds Critical Twist
Ellen Andrews, Ph.D.
ELLEN ANDREWS

Yet another lawsuit against Hartford Healthcare (HHC) may seem obscure and limited to healthcare, but it goes much further. There is overwhelming evidence that prices for care at huge health systems like HHC are driving up healthcare prices for private health plans in Connecticut and it’s getting worse.

The third anti-trust lawsuit against HHC outlines how they get around a new law to prohibit anti-competitive behavior by luring independent practices into exclusive agreements that keep thousands of Connecticut physicians from contracting with more affordable plans. New research connects the broader impact of these price hikes with layoffs and other economic harms beyond healthcare. It’s a big deal.

HHC is a massive presence in Connecticut. According to HHC, they employ over 41,000 people at nearly 500 locations and generate $5.4 billion in revenue annually. HHC includes seven hospitals, several of which are the only hospital in their area. HHC also includes behavioral health facilities, ambulatory centers, urgent care centers, home care providers, rehab, and senior service providers.

The new lawsuit, brought by two Connecticut health plans, builds on two earlier suits against HHC, one on behalf of consumers and another by St. Francis, a competitor to HHC. All three allege that HHC uses its sizeable monopoly power in some areas of the state to limit competition and demand much higher prices across Connecticut. According to the complaint, residents in and around Meriden, Willimantic, Norwich, and Torrington only have access to an HHC-owned hospital. These are termed “must-have” hospitals. Insurers cannot offer plans to residents of those areas without paying HHC’s high prices.

But it’s worse than that. Even in Bridgeport and Hartford, where there are competitor hospitals, HHC can require that their hospitals and other facilities be included in insurer networks, even if they are higher priced and lower quality than competing hospitals, as a condition of getting the must-have hospitals. When they know they must be included, they can demand excessive prices.

It’s important to note that HHC’s monopoly powers only raise costs for private insurance and employer plans which have to negotiate prices with HHC. Medicare and Medicaid prices are set by the government and are not affected by HHC’s market leverage.

According to the latest complaint, HHC is also using its market power to block more affordable health plan options that are saving money for people in other states. Tiered plans give patients the option of using higher-quality, lower-price providers at a lower cost to them. Patients can still choose to access care from lower-tier providers, they just have to pay more.

But Connecticut doesn’t have tiered plans because HHC uses its monopoly power to get placed on better tiers than they deserve based on price or quality. Tiered plans can save patients money, lower everyone’s insurance premiums, and improve the quality of care while preserving consumer choice. But because of HHC’s anti-competitive conduct alleged in the litigation, tiered plans aren’t viable in Connecticut.

It’s not that the state hasn’t tried to fix this problem. A hard-fought law passed in 2023 made these anti-competitive contract clauses illegal. But the newest lawsuit explains how HHC gets around the law.

Integrated Care Partners LLC (ICP), a for-profit subsidiary of HHC, offers physician practices very lucrative benefits to join their network. Practices can only get referrals from HHC facilities if they join ICP. Providers who join ICP also get the higher HHC monopoly payment rates, far higher than they could negotiate independently. ICP practices also get access to expensive electronic medical record systems that are integrated with HHC hospitals and providers and access to exclusive surgical technology.

It’s a hard deal to resist. Currently, ICP includes 2,173 physicians and advanced practice providers in their network, a large proportion of all Connecticut providers. In many areas of the state, all the providers in several specialties are locked in the ICP network.

According to the newest lawsuit, in return for all these benefits, ICP requires their providers to exclusively contract with HHC and only refer to providers within the HHC network. This effectively prevents an insurer from assembling a viable, competing network that may offer lower costs and better-quality care to consumers and employers. Trapping care referrals and the profits within the HHC network reduces options and access to care for patients. While ICP affiliates may not technically be employees of HHC, they are bound by HHC’s exclusionary policies. According to the complaint, this lack of competition constitutes illegal price-fixing and only serves to increase HHC profits and salaries.

While this lack of competition keeps healthcare unaffordable for Connecticut employers and consumers, new research finds that it also harms employment and the economic health of communities. In a paper published last month, researchers found that communities with higher healthcare prices due to monopoly health systems lost jobs outside healthcare as health benefit costs rose.

In addition to layoffs, wages decreased and tax revenue, to fund safety net services, dropped. The bigger the monopolies, the worse the impact on local economies. Not surprisingly, the researchers also found increases in community suicide and overdose rates. The impact was worst for workers making $20,000 to $100,000 per year. Claims by health systems of increased efficiencies from consolidation are not supported by the evidence.

The attorneys and plaintiffs who’ve brought these lawsuits are providing a key public service to make healthcare affordable here. And Connecticut lawmakers did the right thing passing a law last year to preserve competition and consumer choice. They all deserve our thanks and support.

But HHC seems to have found a way around the law. Hopefully, the combination of the lawsuits and legislative efforts to plug the holes will eventually result in sustainable access to affordable care and patients will have choices.


More from Ellen Andrews

OP-ED | Patient-centered Or Doctor-centered? Primary Care Planning Is Off Track

Several state agencies and their committees are planning to expand primary care in Connecticut – that’s a good thing. But it’s being driven by primary…

Keep reading


OP-ED | Legislators Hear How RI Saved 2 Hospitals From Private Equity, Other Solutions to High Insurance Premiums

Ellen Andrews says that on Friday, the legislature heard from six national and local experts about specific policy tools to help fight health care market…

Keep reading


ANALYSIS | Covered Connecticut Is A Good Start, But Needs Tending

Covered Connecticut – the state’s alternative to a public health insurance option or the restoration of funds that were cut from HUSKY parent coverage –…

Keep reading


OP-ED | Congress Wants to Lower Drug Prices to Fund Important Priorities

Economists argue that rising healthcare costs are crowding out other budget priorities. Ellen Andrews says that policymakers want to make big investments and they’re planning…

Keep reading


OP-ED | Insulin – Once a Gift, Now Serving Greed

Insulin prices now bear no relation to the costs to manufacture it. While newer insulin versions cost $3.69 to $6.16 per vial to manufacture, the…

Keep reading


ANALYSIS | Connecticut Needs to Focus on Real Health Reform

Making healthcare more affordable was the drumbeat from voters last year, but Connecticut policymakers have responded with weak options that kick the can down the…

Keep reading


OP-ED | Controversial New Alzheimer’s Drug Could Break the Bank

Setting aside its questionable effectiveness, the price tag for the new Alzheimer’s drug is simply unaffordable.

Keep reading


ANALYSIS | Who In Health Care Made Money on COVID?

Amidst the heroism of the pandemic, Ellen Andrews writes that some of the biggest winners – financially – are in health care

Keep reading


OP-ED | When Data Becomes An Excuse To Prevent Change

Ellen Andrews writes that it’s one thing to look at data, but another to endlessly reexamine it as a means of avoiding making tough decisions…

Keep reading


OP-ED | Remember Public Health’s Value After COVID Is Gone

The COVID-19 pandemic has focused a bright light on the weakness of the U.S. public health system. Countries with strong public health systems fared much…

Keep reading


OP-ED | Drug Innovation Argument Cuts Both Ways

Ellen Andrews responds to our recent op-ed from Pfizer’s John Burkhardt and says the proposed tax on excessive drug prices increases is a good idea

Keep reading


OP-ED | Making the Public Option Better

Ellen Andrews gives her prescription to improve Connecticut’s public option

Keep reading


OP-ED | Real Conversation Would Beget Lower Health Care Costs

Why is it so hard to get people across the health care system onto the same page and working through problems together? People tend to…

Keep reading


ANALYSIS | If The COVID Vaccine Is Free For Patients, Who Is Paying For It?

Federal law ensures the COVID vaccine will be provided to every American at no cost. So who is paying for it? Because it’s healthcare, the…

Keep reading


OP-ED | State Should Set Uniform, Public Standards For Rationing Health Care

In spite of pressure from advocates, Connecticut has failed to develop a statewide policy for rationing care for COVID-19 patients.

Keep reading


OP-ED | The Recession Is Here, And Healthcare Is In The Center Of It

After the longest economic recovery in US history, we’ve been expecting a recession for a long time. We knew when it came, Connecticut healthcare would…

Keep reading



link

Leave a Reply

Your email address will not be published. Required fields are marked *